期刊文献+

新疆哈萨克族原发性高血压患者高尿酸血症患病率及相关危险因素分析 被引量:7

Prevalence and Associated Risk Factors of Hyperuricemia in Xinjiang Kazaks Patients with Essential Hypertension
原文传递
导出
摘要 目的探讨新疆哈萨克族原发性高血压患者中高尿酸血症的患病率及其影响因素。方法应用四阶段分层整群随机抽样方法入选新疆7个区35岁以上原发性高血压哈萨克族患者1909例,进行问卷、体检、生化指标测定等检查。采用logistic回归分析该人群的高尿酸血症主要影响因素。结果原发性高血压患者高尿酸血症的患病率为4.6%,男性为6.7%,女性为2.2%,男性高于女性(P<0.01);35~45、>45~55、>55~65、>65~75、>75岁各年龄组的原发性高血压患者高尿酸血症患病率分别为4.70%、4.69%、4.60%、3.91%、4.68%。多因素logistic回归分析得到高三酰甘油(OR=1.77,95%CI1.11~2.85)、高胆固醇血症(OR=2.58,95%CI1.62~4.10)、高尿素氮(OR=1.28,95%CI1.11~1.47)、肥胖(OR=1.53,95%CI0.67~3.50)、经常饮酒(OR=2.12,95%CI1.21~3.69)为危险因素。女性(OR=0.38,95%CI0.22~0.68)为保护因素。结论新疆哈萨克族原发性高血压患者高尿酸血症患病率相对较低,性别、高三酰甘油、高胆固醇血症、高尿素氮、肥胖、饮酒等均可影响高尿酸血症患病率,不同性别的影响因素不同。 Objective To investigate the prevalence of hyperuricemia and its associated risk factors in treated and untreated essential hypertensive patients in Xinjiang Kazak area.Methods This cross-section study was performed in 1909 essential hypertensive patients aged 35 years old or over in Xinjiang Kazaks by using a four-stage selected random sampling method.All patients underwent an investigation composed of a standardized questionnaire,physieal and biochemical examination.Risk factors were analyzed by logistic regression model.Results The prevalence of hyperuricemia in hypertensives in Kazaks for the general population was 4.6%,6.7% or 2.2% for the males and females respectively.The males had higher rate than females (P0.01).The prevalence was 4.70%,4.69%,4.60%,3.91% and 4.68% for 35-45,45-55,55-65,65-75,75 and over years old respectively.Multivariate stepwise logistic regression analyzing the significant risk factors showed high triglycerides (OR=1.77,95% CI 1.11-2.85),high total cholesterol (OR=2.58,95% CI 1.62-4.10),high urea nitrogen (OR=1.28,95% CI 1.11-1.47),obesity (OR=1.53,95% CI 0.67-3.50),alcohol drinking (OR=2.12,95% CI 1.21-3.69).Female (OR=0.38,95% CI 0.22-0.68) was the protective factor.Conclusion Essential hyperuricemia is relatively less common in Xinjiang Kazak area hypertensive patients.The associated risk factors of hyperuricemia include alcohol consumption,elevated serum uric acids,high triglycerides,high total cholesterol,high urea nitrogen,obesity.The effect of these factors is different between genders.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2010年第9期832-836,共5页 Chinese Journal of Hypertension
基金 新疆维吾尔自治区重大科技专项课题(200733146-3)
关键词 原发性高血压 高尿酸血症 患病率 危险因素 哈萨克族 Essential hypertension Hyperuricemia Prevalence Risk factor Kazaks
  • 相关文献

参考文献17

  • 1卫生部心血管防治研究中心.中国心血管报鉴2007[M].1版.北京:中国大百科全书出版社.2009:12-13.
  • 2Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation[J]. Hypertension, 2003,42 (4) : 474-480.
  • 3Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosise Risk in Communities (ARIC) study[J]. Ann Epidemiol,2000,10(3) : 136-143.
  • 4中国高血压防治指南编写委员会.中国高血压防治指南(2005年版).2005,13(1):1-41.
  • 5何秉贤,马雷.新疆汉,维吾尔,哈萨克三民族高血压流行病学调查[J].新疆医学,1992,22(4):194-200. 被引量:45
  • 6Johnson RJ, Feig DI, Herrera-Aeosta J, et al. Resurrection of utie acid as a causal risk factor in essential hypertension[J]. Hypertension, 2005,45 ( 1 ) : 18-20.
  • 7Selby JV, Friedman GD, Quesenberry CP Jr, et al. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries[J]. Am J Epidemiol,1990,131(6) :1017-1027.
  • 8De Leeuw PW, Thijs L, Birkenhager WH, etal. Prognostic sig- nificance of renal function in elderly patients with isolated systolic hypertension., results from the Syst-Eur trial [J]. J Am Soc Nepnrol, 2002,13(9) : 2213-2222.
  • 9Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men[J]. Eur J Cardiovasc Prey Rehabil,2004,11(3) :185-191.
  • 10党爱民,刘国仗.尿酸与心血管事件[J].中华心血管病杂志,2003,31(6):478-480. 被引量:244

二级参考文献45

  • 1[1]Jossa F,Farinaro E,Panico S,et al. J Hum Hypertens, 1994; 8 (9): 677 ~ 681
  • 2[2]Abbott RD,Brand FN,Kannel WB,et al. J Clin Epidemiol, 1988; 41 (3): 237 ~ 242
  • 3[3]Freedman DS, Williamson DF, Gunter EW, et al. Am J Epidemiol, 1995; 141 (7): 637~ 644
  • 4[4]Tykarski A. Nephron,1991;59(3):364~368
  • 5[5]Alderman MH, Cohen H, Madhavan S, et al.Hypertension, 1999; 34(1): 144~ 150
  • 6[6]Bengtsson C, Lapidus L,Stendahl C, et al. Acta Med Scand,1988; 224 (6): 549~ 555
  • 7[7]Casiglia E, Spolaore P,Ginocchio G, et al. Eur J Epidemiol, 1993; 9(6): 577~ 586
  • 8[8]Lehto S,Niskanen L, Ronnemaa T, et al.Stroke, 1998;29(3) :635~639
  • 9[9]Roch - Ramel F, Guisan B, Diezi J. Pharmcol Exp Ther, 1997;280(2) :839~845
  • 10[10]Rieder MJ,Roman RJ,Greene AS. Hypertension, 1997; 30( 1 pt 1 ): 120~ 127

共引文献475

同被引文献82

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部